A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 664-672

  Bhattacharya, Raktima ^a   Xu, Yan ^a   Rahman, Md Ashequr ^a   Couraud, Pierre Olivier ^b   Romero, Ignacio A ^c   Weksler, Babette B ^d   Weidanz, Jon A ^e   Bickel, Ulrich ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b INSTITUT COCHIN   (France)

^c OPEN UNIVERSITY   (United Kingdom)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIBODY; BETA ACTIN; BIOCHEMICAL MARKER; CAVEOLIN 1; EARLY ENDOSOME ANTIGEN 1; EPITOPE; HISTIDINE; HLA A2 ANTIGEN; ISOLEUCINE; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN P68; RNA HELICASE; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TYROSINE; VALINE; CAV1 PROTEIN, HUMAN; CD31 ANTIGEN; DEAD BOX PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; CELL IMMORTALIZATION; CELL ISOLATION; CELL MEMBRANE; CONTROLLED STUDY; ENDOSOME; ENDOTHELIUM CELL; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE VESICLE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CONFOCAL MICROSCOPY; CYTOLOGY; ENDOCYTOSIS; GENETICS; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; METABOLISM; MOLECULAR MIMICRY; NONOBESE DIABETIC MOUSE; RNA INTERFERENCE; VASCULARIZATION;

MUS MUSCULUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, CD31; BLOOD-BRAIN BARRIER; BRAIN; CAVEOLIN 1; CELLS, CULTURED; DEAD-BOX RNA HELICASES; ENDOCYTOSIS; ENDOSOMES; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; IMMUNOMAGNETIC SEPARATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MOLECULAR MIMICRY; RECEPTORS, ANTIGEN, T-CELL; RNA INTERFERENCE; VESICULAR TRANSPORT PROTEINS;

EID: 77957830071     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22256     Document Type: Article

References (45)

1. Agarwal N, Shusta EV. 2009. Multiplex expression cloning of blood-brain barrier membrane proteins. Proteomics 9: 1099-1108.
2. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R. 2002. Steps toward mapping the human vasculature by phage display. Nat Med 8: 121-127.
3. Bates GJ, Nicol SM, Wilson BJ, Jacobs AM, Bourdon JC, Wardrop J, Gregory DJ, Lane DP, Perkins ND, Fuller-Pace FV. 2005. The DEAD box protein p68: A novel transcriptional coactivator of the p53 tumour suppressor. EMBO J 24: 543-553.
4. Bertrand Y, Currie JC, Demeule M, Regina A, Che C, Abulrob A, Fatehi D, Sartelet H, Gabathuler R, Castaigne JP, Stanimirovic D, Beliveau R. 2009. Transport characteristics of a novel peptide platform for CNS therapeutics. J Cell Mol Med. [Epub ahead of print].
5. Bickel U, Yoshikawa T, Landaw EM, Faull KF, Pardridge WM. 1993. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci USA 90: 2618-2622.
6. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232.
7. Borvak J, Richardson J, Medesan C, Antohe F, Radu C, Simionescu M, Ghetie V, Ward ES. 1998. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol 10: 1289-1298.
8. Deane R, Sagare A, Hamm K, Parisi M, LaRue B, Guo H, Wu Z, Holtzman DM, Zlokovic BV. 2005. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J Neurosci 25: 11495-11503.
9. Demeule M, Labelle M, Regina A, Berthelet F, Beliveau R. 2001. Isolation of endothelial cells from brain, lung, and kidney: Expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun 281: 827-834.
10. Denkberg G, Reiter Y. 2006. Recombinant antibodies with T-cell receptor-like specificity: Novel tools to study MHC class I presentation. Autoimmun Rev 5: 252-257.
11. Donaldson JG, Williams DB. 2009. Intracellular assembly and trafficking of MHC class I molecules. Traffic (Copenhagen, Denmark) 10: 1745-1752.
12. Enerson BE, Drewes LR. 2006. The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26: 959-973.
13. Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH. 2008. Identification of breast cancer peptide epitopes presented by HLA-A*0201. J Proteome Res 7: 1445-1457.
14. Hickman HD, Luis AD, Buchli R, Few SR, Sathiamurthy M, VanGundy RS, Giberson CF, Hildebrand WH. 2004. Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J Immunol 172: 2944-2952.
15. Huet C, Ash JF, Singer SJ. 1980. The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblasts. Cell 21: 429-438.
16. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261-1263.
17. Iggo RD, Lane DP. 1989. Nuclear protein p68 is an RNA-dependent ATPase. EMBO J 8: 1827-1831.
18. Jones AR, Shusta EV. 2007. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24: 1759-1771.
19. Lassmann H, Rossler K, Zimprich F, Vass K. 1991. Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier. Brain Pathol 1: 115-123.
20. Li JY, Boado RJ, Pardridge WM. 2002. Rat blood-brain barrier genomics. II. J Cereb Blood Flow Metab 22: 1319-1326.
21. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, Arnold B, Knolle PA. 2000. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6: 1348-1354.
22. Lizee G, Basha G, Jefferies WA. 2005. Tails of wonder: Endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol 26: 141-149.
23. Machy P, Truneh A, Gennaro D, Hoffstein S. 1987. Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes. Nature 328: 724-726.
24. Male D, Pryce G. 1988. Kinetics of MHC gene expression and mRNA synthesis in brain endothelium. Immunology 63: 37-42.
25. Middleton D, Menchaca L, Rood H, Komerofsky R. 2003. New allele frequency database. Tissue Antigens 61: 403-407.
26. Naslavsky N, Weigert R, Donaldson JG. 2003. Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol Biol Cell 14: 417-431.
27. Naslavsky N, Weigert R, Donaldson JG. 2004. Characterization of a nonclathrin endocytic pathway: Membrane cargo and lipid requirements. Mol Biol Cell 15: 3542-3552.
28. Newberg MH, Smith DH, Haertel SB, Vining DR, Lacy E, Engelhard VH. 1996. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J Immunol 156: 2473-2480.
29. Pardridge WM. 2007. Blood-brain barrier delivery. Drug Discov Today 12: 54-61.
30. Pardridge WM, Kang YS, Buciak JL, Yang J. 1995. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res 12: 807-816.
31. Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier FA, Perarnau B. 1997. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185: 2043-2051.
32. Pelkmans L, Burli T, Zerial M, Helenius A. 2004. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118: 767-780.
33. Reiter Y, Di Carlo A, Fugger L, Engberg J, Pastan I. 1997. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity. Proc Natl Acad Sci USA 94: 4631-4636.
34. Rossler OG, Hloch P, Schutz N, Weitzenegger T, Stahl H. 2000. Structure and expression of the human p68 RNA helicase gene. Nucleic Acids Res 28: 932-939.
35. Schlachetzki F, Zhu C, Pardridge WM. 2002. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81: 203-206.
36. Serreze DV, Marron MP, Dilorenzo TP. 2007. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Ann NY Acad Sci 1103: 103-111.
37. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV. 2006. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176: 3257-3265.
38. Tse DB, Pernis B. 1984. Spontaneous internalization of Class I major histocompatibility complex molecules in T lymphoid cells. J Exp Med 159: 193-207.
39. Verma B, Hawkins OE, Neethling FA, Caseltine SL, Largo SR, Hildebrand WH, Weidanz JA. 2010a. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother 59: 563-573.
40. Verma B, Neethling FA, Caseltine S, Fabrizio G, Largo S, Duty JA, Tabaczewski P, Weidanz JA. 2010b. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol 184: 2156-2165.
41. Weidanz JA, Nguyen T, Woodburn T, Neethling FA, Chiriva-Internati M, Hildebrand WH, Lustgarten J. 2006. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol 177: 5088-5097.
42. Weidanz JA, Piazza P, Hickman-Miller H, Woodburn D, Nguyen T, Wahl A, Neethling F, Chiriva-Internati M, Rinaldo CR, Hildebrand WH. 2007. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods 318: 47-58.
43. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. 2005. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874.
44. Zhang Y, Pardridge WM. 2001. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol 114: 168-172.
45. Zhou J, Mateos F, Ober RJ, Ward ES. 2005. Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis. J Mol Biol 345: 1071-1081.